Allan Böhm, MD, MSc, PhD, MBA, FESC, FJCS is an established Slovak cardiologist and scientist, known for his pioneering work in precision medicine. He is the founder and CEO of Premedix, a leading research organization and clinic in precision medicine, where he also serves as a scientist and practicing cardiologist. In 2022, he expanded his entrepreneurial ventures by founding Seerlinq, a med-tech startup specializing in the development of artificial intelligence algorithms for the diagnosis and remote monitoring of cardiovascular patients.
From 2015 to 2023, he worked as a cardiologist in the Department of Acute Cardiology at the National Institute of Cardiovascular Diseases. He expanded his academic education by completing MSc in Clinical trials at Oxford University in 2023. Dr. Böhm focuses not only on clinical medicine but also intensely on research in the areas of cardiovascular diseases, tele-medicine and artificial intelligence, leading to numerous significant publications and awards.
In 2015, he founded Premedix Academy, a biomedical organization dedicated to education and research in precision medicine. Two years later, in 2017, he was invited by the European Society of Cardiology to co-found the Committee for Digital Health, which played a crucial role in introducing the concept of precision medicine to Slovakia, leading to the creation of Premedix Clinic.
Dr. Böhm became the first Slovak and the youngest ever member of the board of the European Society of Cardiology in 2020. In 2022, he was awarded the Silver Medal of this prestigious society and was named among the top 5 young scientists in Slovakia.